GEN Stock Chart & Stats
zł25.20
--
Market closed
zł25.20
--
Day’s Range― - ―
52-Week Rangezł15.40 - zł33.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)14.00
Market Cap
zł37.79M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)12.3
Beta0.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,321,301
10 Day Avg. Volume12
30 Day Avg. Volume14
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GEN FAQ
What was Genomed S.A.’s price range in the past 12 months?
Genomed S.A. lowest stock price was zł15.40 and its highest was zł33.00 in the past 12 months.
What is Genomed S.A.’s market cap?
Genomed S.A.’s market cap is zł37.79M.
When is Genomed S.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Genomed S.A.’s earnings last quarter?
Currently, no data Available
Is Genomed S.A. overvalued?
According to Wall Street analysts Genomed S.A.’s price is currently Overvalued.
Does Genomed S.A. pay dividends?
Genomed S.A. does not currently pay dividends.
What is Genomed S.A.’s EPS estimate?
Genomed S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genomed S.A. have?
Genomed S.A. has 1,321,301 shares outstanding.
What happened to Genomed S.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Genomed S.A.?
Currently, no hedge funds are holding shares in PL:GEN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology